Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies
- PMID: 21544812
- DOI: 10.1002/ijc.26165
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies
Abstract
In recent years, increasing evidence has suggested a strong association between diabetes mellitus (DM) and hepatocellular carcinoma (HCC). To provide a quantitative assessment of this association, we performed a systematic review and meta-analysis of cohort studies. We collected studies through a literature search of Medline from January 1, 1966 and EMBASE from January 1, 1974, through July 31, 2010. Summary relative risks (SRRs) with their corresponding 95% confidence intervals (CIs) were calculated using a random-effects model. A total of 25 cohort studies that met our inclusion and exclusion criteria were included in our analysis. Among these, 18 studies showed that DM was associated with an increased incidence of HCC (SRRs = 2.01, 95% CI: 1.61-2.51), compared with individuals without DM. There was a statistically significant heterogeneity among these studies (Q = 136.68, p < 0.001, I(2) = 87.6%). Analyses subgrouped by controlling confounders revealed that the increased incidence of HCC was independent of geographic location, alcohol consumption, history of cirrhosis, or infections with hepatitis B (HBV) or hepatitis C virus (HCV). In addition, DM was also positively associated with HCC mortality (SRR = 1.56; 95% CI: 1.30-1.87), with no significant evidence of heterogeneity among studies (Q = 1.16, p = 0.56, I(2) =0%). There were no significant publication bias (p = 0.79 for Egger's regression asymmetry test). These findings strongly support a positive association between DM and increased risk of HCC in both males and females.
Copyright © 2011 UICC.
Similar articles
-
Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies.Eur J Cancer Prev. 2015 Mar;24(2):89-99. doi: 10.1097/CEJ.0000000000000038. Eur J Cancer Prev. 2015. PMID: 24809655
-
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.Hepatology. 2002 Nov;36(5):1206-13. doi: 10.1053/jhep.2002.36780. Hepatology. 2002. PMID: 12395331
-
Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.Cancer. 2018 Jul 1;124(13):2748-2757. doi: 10.1002/cncr.31406. Epub 2018 Apr 18. Cancer. 2018. PMID: 29669170
-
Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence.Oncogene. 2006 Jun 26;25(27):3756-70. doi: 10.1038/sj.onc.1209557. Oncogene. 2006. PMID: 16799617 Review.
-
The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?Am J Gastroenterol. 2003 Nov;98(11):2535-42. doi: 10.1111/j.1572-0241.2003.07678.x. Am J Gastroenterol. 2003. PMID: 14638360 Review.
Cited by
-
Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort.Ann Oncol. 2013 Sep;24(9):2449-55. doi: 10.1093/annonc/mdt204. Epub 2013 May 29. Ann Oncol. 2013. PMID: 23720454 Free PMC article.
-
The Role of Type 2 Diabetes Mellitus-Related Risk Factors and Drugs in Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2024 Jan 19;11:159-171. doi: 10.2147/JHC.S441672. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 38268569 Free PMC article. Review.
-
Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients.J Gastroenterol. 2019 Jan;54(1):64-77. doi: 10.1007/s00535-018-1494-7. Epub 2018 Jul 13. J Gastroenterol. 2019. PMID: 30006904
-
Nonalcoholic fatty liver disease and hepatocellular carcinoma.Hepat Oncol. 2017 Jul;4(3):83-98. doi: 10.2217/hep-2017-0013. Epub 2017 Oct 30. Hepat Oncol. 2017. PMID: 30191057 Free PMC article. Review.
-
Comorbidities as an Indication for Metabolic Surgery.Visc Med. 2018 Oct;34(5):381-387. doi: 10.1159/000493291. Epub 2018 Oct 28. Visc Med. 2018. PMID: 30498706 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous